PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
August 5, 20250 citations

Prognostic value of hemoglobin to red cell distribution width ratio in patients with pulmonary embolism

View Full Paper
JLJian LiaoDLDingyu LuMWMaojuan Wang

Key Points

  • Main finding indicates that lower HRR levels are associated with poorer prognosis and increased mortality in pulmonary embolism patients.
  • Patients in higher HRR quartiles demonstrated significantly improved survival rates at both 28 and 90 days after diagnosis.
  • Cohort study analyzed data from 1,658 critically ill patients, utilizing various statistical methods to assess HRR's prognostic value.
  • HRR levels serve as a novel, cost-effective biomarker for predicting mortality, highlighting its potential clinical significance in treatment planning.

Abstract

Abstract Background his study investigates the prognostic value of the hemoglobin to red cell distribution width ratio (HRR) in pulmonary embolism (PE), a life-threatening cardiovascular disease. While inflammation and hypercoagulability drive PE pathogenesis, the role of HRR remains unexplored. Methods In this retrospective cohort study, data from 1,658 critically ill PE patients (2008–2022) were extracted from the MIMIC-IV database. Patients were stratified by HRR quartiles (Q1–Q4). COX proportional hazards regression analysis, Kaplan- Meier survival curves and restricted cubic spline models were employed to investigate the association of RDW and HRR levels with mortality. Time-dependent receiver operating characteristic curve (ROC) analysis was conducted to evaluate the accuracy of RDW and HRR in predicting mortality in patients with PE. Results Patients with a poor prognosis and mortality had significantly lower HRR levels at admission. When HHR was considered as a continuous variable, HRR was inversely associated with 28-day mortality (HR = 0.44, 95% CI = 0.22–0.86, p Conclusions HRR levels as a simple, novel, cost-effective, and valuable biomarker, are an independent predictor of poor prognosis for patients with pulmonary embolism. However, further research is necessary to elucidate the underlying biological mechanisms and confirm the clinical utility of HRR.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Liao et al. (2025) studied this question.

synapsesocial.com/papers/689a0f99e6551bb0af8d1446https://doi.org/10.21203/rs.3.rs-6888191/v1
Ask AI
Helpful
Bookmark
Share
View Full Paper